Physitrack Q3 2026 swings to EUR 100,000 net profit from continuing operations from year-earlier loss; Q3 2026 revenue rises 14% year on year to EUR 3.6 million

Bitget2026/10/20 06:08

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Physitrack's Q3 2026 adjusted EBITDA fell 8% year-over-year to EUR 1.1 million, reflecting investment in North American commercial operations and product launches.
Revenue rose 14% year-over-year to EUR 3.6 million.
Two US healthcare systems selected its platform in September, with contracting underway at a large academic healthcare system.
Early access to its new electronic medical record product attracted 480 clinics representing over 4,700 users.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Physitrack plc published the original content used to generate this news brief on October 20, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Physitrack Q3 2026 swings to EUR 100,000 net profit from continuing operations from year-earlier loss; Q3 2026 revenue rises 14% year on year to EUR 3.6 million

You may also like

Crypto prices